Literature DB >> 8617200

Association of the small latent transforming growth factor-beta with an eight cysteine repeat of its binding protein LTBP-1.

J Saharinen1, J Taipale, J Keski-Oja.   

Abstract

Transforming growth factor-betas (TGF-betas) are produced by most cells in large latent complexes of TGF-beta and its propeptide (LAP) associated with a binding protein. The latent TGF-beta binding proteins (LTBPs-1, -2 and -3) mediate the secretion and, subsequently, the association of latent TGF-beta complexes with the extracellular matrix (ECM). The association of beta1-LAP with LTBP-1 was characterized at the molecular level with an expression system in mammalian cells, where TGF-beta1 and various fragments of LTBP-1 were co-expressed and secreted with the aid of a signal peptide synthesized to the LTBP-1 constructs. Immunoblotting of the fusion protein complexes indicated that the third 8-Cys repeat of LTBP-1 bound covalently to the LAP region of TGF-beta1. The cysteine required for the association between LTBP-1 and beta1-LAP was mapped to Cys33 of beta1-LAP. The N-terminal region of LTBP-1 consisting of the first 400 amino acids was found to associate covalently with the ECM. The data indicate that an 8-Cys repeat of LTBP is capable of covalent and specific protein-protein interactions. These interactions are mediated by exchanging cysteine disulfide bonds between the core 8-Cys repeat and an optionally associated protein during the secretion. This is, to our knowledge, the first demonstration of an extracellular protein module that is able to exchange cysteine disulfide bonds with heterologous ligand proteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617200      PMCID: PMC449939     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

1.  Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor.

Authors:  D F Stern; D L Hare; M A Cecchini; R A Weinberg
Journal:  Science       Date:  1987-01-16       Impact factor: 47.728

Review 2.  Structure and function of epidermal growth factor-like regions in proteins.

Authors:  E Appella; I T Weber; F Blasi
Journal:  FEBS Lett       Date:  1988-04-11       Impact factor: 4.124

3.  Lack of the latent transforming growth factor beta binding protein in malignant, but not benign prostatic tissue.

Authors:  S Eklöv; K Funa; H Nordgren; A Olofsson; T Kanzaki; K Miyazono; S Nilsson
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

4.  TGF-beta 1 binding protein: a component of the large latent complex of TGF-beta 1 with multiple repeat sequences.

Authors:  T Kanzaki; A Olofsson; A Morén; C Wernstedt; U Hellman; K Miyazono; L Claesson-Welsh; C H Heldin
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

5.  Retention of the transforming growth factor-beta 1 precursor in the Golgi complex in a latent endoglycosidase H-sensitive form.

Authors:  K Miyazono; J Thyberg; C H Heldin
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

6.  Transforming growth factor-beta 1, -beta 2, and -beta 3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes.

Authors:  A Olofsson; K Miyazono; T Kanzaki; P Colosetti; U Engström; C H Heldin
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

7.  Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes.

Authors:  B Lee; M Godfrey; E Vitale; H Hori; M G Mattei; M Sarfarazi; P Tsipouras; F Ramirez; D W Hollister
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

8.  Role for carbohydrate structures in TGF-beta 1 latency.

Authors:  K Miyazono; C H Heldin
Journal:  Nature       Date:  1989-03-09       Impact factor: 49.962

9.  Identification and characterization of LTBP-2, a novel latent transforming growth factor-beta-binding protein.

Authors:  A Morén; A Olofsson; G Stenman; P Sahlin; T Kanzaki; L Claesson-Welsh; P ten Dijke; K Miyazono; C H Heldin
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

10.  The mechanism for the activation of latent TGF-beta during co-culture of endothelial cells and smooth muscle cells: cell-type specific targeting of latent TGF-beta to smooth muscle cells.

Authors:  Y Sato; F Okada; M Abe; T Seguchi; M Kuwano; S Sato; A Furuya; N Hanai; T Tamaoki
Journal:  J Cell Biol       Date:  1993-12       Impact factor: 10.539

View more
  63 in total

1.  Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta.

Authors:  J Saharinen; J Keski-Oja
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

Review 2.  The molecular genetics of Marfan syndrome and related microfibrillopathies.

Authors:  P N Robinson; M Godfrey
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

3.  Novel functional single nucleotide polymorphisms in the latent transforming growth factor-beta binding protein-1L promoter: effect on latent transforming growth factor-beta binding protein-1L expression level and possible prognostic significance in ovarian cancer.

Authors:  Tomomi Higashi; Satoru Kyo; Masaki Inoue; Hideji Tanii; Kiyofumi Saijoh
Journal:  J Mol Diagn       Date:  2006-07       Impact factor: 5.568

Review 4.  LTBPs in biology and medicine: LTBP diseases.

Authors:  Daniel B Rifkin; William J Rifkin; Lior Zilberberg
Journal:  Matrix Biol       Date:  2017-12-05       Impact factor: 11.583

Review 5.  The microRNA networks of TGFβ signaling in cancer.

Authors:  V P Sivadas; S Kannan
Journal:  Tumour Biol       Date:  2013-12-10

6.  Effects of proline cis-trans isomerization on TB domain secondary structure.

Authors:  X Yuan; J M Werner; V Knott; P A Handford; I D Campbell; K Downing
Journal:  Protein Sci       Date:  1998-10       Impact factor: 6.725

7.  Latent transforming growth factor-beta-binding protein-4 regulates transforming growth factor-beta1 bioavailability for activation by fibrogenic lung fibroblasts in response to bleomycin.

Authors:  Yong Zhou; Katri Koli; James S Hagood; Mi Miao; Mahendra Mavalli; Daniel B Rifkin; Joanne E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2008-12-04       Impact factor: 4.307

8.  An ADAMTSL2 founder mutation causes Musladin-Lueke Syndrome, a heritable disorder of beagle dogs, featuring stiff skin and joint contractures.

Authors:  Hannah L Bader; Alison L Ruhe; Lauren W Wang; Aaron K Wong; Kari F Walsh; Rebecca A Packer; Jonathan Mitelman; Kathryn R Robertson; Dennis P O'Brien; Karl W Broman; G Diane Shelton; Suneel S Apte; Mark W Neff
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

9.  LTBP2 null mutations in an autosomal recessive ocular syndrome with megalocornea, spherophakia, and secondary glaucoma.

Authors:  Julie Désir; Yves Sznajer; Fanny Depasse; Françoise Roulez; Marc Schrooyen; Françoise Meire; Marc Abramowicz
Journal:  Eur J Hum Genet       Date:  2010-02-24       Impact factor: 4.246

10.  Expression and regulation of latent TGF-beta binding protein-1 transcripts and their splice variants in human glomerular endothelial cells.

Authors:  Joon Hyeok Kwak; Ji Su Woo; Kunyoo Shin; Hee Joon Kim; Hoe Su Jeong; Dong Cheol Han; Sung Il Kim; Choon Sik Park
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.